Pharmaceutical giant Johnson & Johnson helped fund a 1960s prison experiment when a group of majority-black Pennsylvania prisoners were injected with asbestos to determine whether the substance was safe to use in talcum powder.
Documents confirming the company’s involvement were obtained by Bloomberg, tying the New Jersey-based company to controversial experiments led by Dr Albert Kligman, a University of Pennsylvania dermatologist whose human experiments have widely condemned as brutal and unethical. He died in 2010 aged 93.
Inmates at Holmesburg Prison in Philadelphia, Pennsylvania, were offered $10 to $300 – equivalent to between $100 to $2,500 in today’s money when adjusted for inflation – to take part in the study – though they were likely unaware of the significant risk they were undertaking.
Participants were injected with asbestos and talc – a powder that forms the base of J&J’s iconic baby powder product. Asbestos is an extremely dangerous chemical that is tied to lung cancers, among other conditions.
The European Union’s drug regulator on Oct. 1 recommended updating the label for Johnson & Johnson’s COVID-19 vaccine with warnings for two more serious health conditions likely linked with the vaccine.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded that the use of the J&J vaccine is possibly linked with vein clotting and an immune condition that causes the immune system to attack blood platelets.
“The PRAC has concluded that there is a possible link to rare cases of venous thromboembolism (VTE) with COVID-19 Vaccine Janssen,” the committee meeting highlights stated.
Venous thromboembolism “is a condition in which a blood clot forms in a deep vein, usually in a leg, arm, or groin, and may travel to the lungs causing a blockage of the blood supply, with possible life-threatening consequences,” the committee said.
Janssen, a J&J company, did not respond to a request for comment.
After reviewing new evidence, PRAC concluded that there is a “reasonable possibility” that the clotting condition is linked with vaccination using the J&J vaccine. The committee recommended listing venous thromboembolism as a rare side effect in the product information for the J&J vaccine.
The committee also found that the use of the J&J and the AstraZeneca vaccines is linked to an immune condition that causes the body’s immune system to target healthy platelets needed for normal blood clotting.
Project Veritas is out with the third installment of their series on vaccine insiders – this time covertly recording two Johnson & Johnson officials saying that children don’t shouldn’t take the Covid-19 jab.
“Kids shouldn’t get a f*cking [COVID] vaccine,” said regional business lead, Brandon Schatt.
“It’s a kid, you just don’t do that, you know? Not something that’s so unknown in terms of repercussions down the road, you know?”
Schadt also implied that the huge push to vaccinate children is about money, not public safety.
“J&J is like stepping in the best smelling pile of sh*t you could step in,” he said.
Another J&J employee, scientist Justin Durrant, explicitly said “Don’t get the Johnson & Johnson [COVID vaccine], I didn’t tell you though.”
As for children, Durrant said “It wouldn’t make that much of a difference.”
He also commented on the pressure campaign to restrict social privileges for the unvaccinated.
The U.S. Food and Drug Administration (FDA) is set to announce a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease.
Four people familiar with the situation told The Washington Post that the shot has caused instances of Guillain-Barré syndrome, a rare disorder in which the immune system attacks the peripheral nervous system, temporarily paralyzing parts of the body.
The Centers for Disease Control and Prevention (CDC) is said to have received about 100 preliminary reports of Guillain-Barré following the one-dose vaccine
Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older.
With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.
The warning is yet another setback for J&J’s vaccine, which has plagued by pauses, ingredient mix-ups and doses needing to be thrown out.
New blood disorder warnings appear on the Johnson and Johnson (Janssen) Covid-19 vaccine label, now that the federal “pause” on administering the vaccine has ended.
The warnings flag an increased risk of thrombosis, clotting of the blood in the circulatory system. This disorder can be combined with thrombocytopenia, or low blood platelet count, which can lead to dangerous internal bleeding, according to the new warnings. The warnings say the symptoms can appear approximately one to two weeks after vaccination.
A 56-year old Miami Beach doctor, Gregory Michael, died of the rare blood disorder two weeks after his Dec. 18 vaccination with a different brand: Pfizer/BioNTech’s Covid-19 vaccine. However, his official cause of death was ruled to be “natural.” Dr. Michael was described as “very healthy” before his Covid-19 vaccine and sudden onset of “immune thrombocytopenia,” or low blood platelet count. There is no word as to whether officials have reclassified or reinvestigated his death.
One reason why relatively rare reports of a serious adverse event are cause for such concern and added warnings is that scientists have documented that they only capture a small percentage of actual illnesses that occur.
Each recognized case is presumed to represent many more that are not correctly diagnosed or reported to the Vaccine Adverse Event Reporting System or VAERS. Patients and doctors are encouraged to report all illnesses after vaccination to VAERS, whether they are proven to be linked to the inoculation or not. As professionals comb through the data, they are able to identify previously unknown side effects.
Several European countries report similar blood clot complications after use of AstraZeneca’s Covid-19 vaccine.
Federal inspectors identified a series of problems at the Baltimore facility where the ingredients for up to 15 million doses of Johnson & Johnson vaccine were ruined, according to a Food and Drug Administration report obtained by NBC News.
The report, known as FDA Form 483, says the plant operated by Emergent BioSolutions “is not maintained in a clean and sanitary condition.” Inspectors found peeling paint and unidentified black and brown residue on the floors and walls, as well as a failure to properly decontaminate waste generated during the manufacture of the vaccine drug substance.
Officials are investigating the death of a University of Cincinnati student one day after he received Johnson & Johnson’s one-dose COVID-19 vaccine.
John Foley, 21, a pre-med junior, passed away on Sunday. His body was discovered shortly afterwards by his college roommates, reported FOX 19.
The Ohio Department of Health and the Hamilton County Coroner’s Office are awaiting medical records and test results before determining the cause of death.
It comes as the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) announced on Tuesday they were recommending a pause of the shot after six women developed rare, but serious, blood clots out of 7.2 million vaccinations.